Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05979883 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 204
- Enrollment target
NCT05979883: Completed NA study, sponsored by Mayo Clinic.
NCT05979883 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 204 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05979883, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the magnitude of clinical benefit achieved through machine learning assisted radiation treatment planning (MLAP) on post-treatment clinical outcomes such as acute toxicity and patient reported outcomes.
Primary Outcome
Will be assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck module (EORTC QLQ-H\&N35). The EORTC QLQ-H\&N35 is a 35-item questionnaire used to assess symptoms encountered specifically by patients with head and neck cancer. The H\&N35 consists of 7 multiple-item scales (Pain, Swallowing, Senses, Speech, Social eating, Social contact, and Sexuality), in addition to 11 single items (e.g., Opening mouth, Sticky saliva, Dry mouth,
Interventions
- RADIATION Machine Learning Assisted Radiation (MLAP) RapidPlan
- RADIATION Radiation Therapy Standard of Care (SOC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2023-08-07 |
| Est. Completion | 2025-10-29 |
| Phase | NA |
What the finished NCT05979883 record still lists
NCT05979883 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Machine Learning Assisted Radiation (MLAP) RapidPlan is the first listed.
NCT05979883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05979883 about?
NCT05979883 is a clinical study titled "Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning". The purpose of this study is to determine the magnitude of clinical benefit achieved through machine learning assisted radiation treatment planning (MLAP) on post-treatment clinical outcomes such as acute toxicity and patient reported outcomes.
What is the current status of trial NCT05979883?
This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2023-08-07. Estimated completion is 2025-10-29.
What interventions are being tested in trial NCT05979883?
The interventions under investigation include: Machine Learning Assisted Radiation (MLAP) RapidPlan (RADIATION), Radiation Therapy Standard of Care (SOC) (RADIATION).
Who is sponsoring clinical trial NCT05979883?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05979883's enrollment target sits among peer trials
204 500th of 2000 higher than 1,497 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI